Advertisement
Loading...

GSK plc

GSK•NYSE
Healthcare
Drug Manufacturers - General
$49.67
$-1.29(-2.53%)
U.S. Market opens in 27h 4m

GSK plc (GSK) Stock Overview

Explore GSK plc’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap99.9B
P/E Ratio12.84
EPS (TTM)$3.87
ROE0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$53.84
3 Months$60.48
1 Year Target$57.73

GSK Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of GSK plc (GSK) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 31.74, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $57.73.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 12.84 and a market capitalization of 99.9B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.54%
5-Day Change
-1.67%
1-Month Change
-14.09%
3-Month Change
-15.72%
6-Month Change
5.27%
Year-to-Date (YTD) Change
1.27%
1-Year Change
32.19%
3-Year Change
35.03%
5-Year Change
25.45%
All-Time (Max) Change
7468.00%

Contact Information

https://www.gsk.com
44 20 8047 5000
980 Great West Road, Brentford, NaN, TW8 9GS

Company Facts

68,629 Employees
IPO DateMar 28, 1980
CountryGB
Actively Trading

Frequently Asked Questions